Multiple inflammasome complexes are activated in autistic spectrum disorders

Brain, Behavior, and Immunity

Volumn 57, Issue , 2016, Pages 125-133

  Saresella, Marina ^a   Piancone, Federica ^a   Marventano, Ivana ^a   Zoppis, Martina ^a   Hernis, Ambra ^a   Zanette, Michela ^a   Trabattoni, Daria ^b   Chiappedi, Matteo ^d   Ghezzo, Alessandro ^e   Canevini, Maria Paola ^c   la Rosa, Francesca ^a   Esposito, Susanna ^c   Clerici, Mario ^a,c  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autistic spectrum disorders (ASD); IFABP; Inflammasome; Neuroinflammation; NLRP3

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 5; CRYOPYRIN; FATTY ACID BINDING PROTEIN 2; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 33; INTERLEUKIN 37; LIPOPOLYSACCHARIDE; PROTEIN AIM2; PROTEIN PYCARD; UNCLASSIFIED DRUG; AIM2 PROTEIN, HUMAN; DNA BINDING PROTEIN; FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; INTERLEUKIN DERIVATIVE; NLRP3 PROTEIN, HUMAN;

ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTESTINE MUCOSA PERMEABILITY; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TRANSPORT; UPREGULATION; BLOOD; GASTROINTESTINAL DISEASE; INFLAMMATION; PRESCHOOL CHILD;

AUTISM SPECTRUM DISORDER; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FATTY ACID-BINDING PROTEINS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERLEUKINS; MALE; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN;

EID: 84961233504     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.03.009     Document Type: Article

References (57)

1. Agostini, L., Martinon, F., Burns, K., McDermott, M.F., Hawkins, P.N., Tschopp, J., NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20 (2004), 319–325.
2. Alabdali, A., Al-Ayadhi, L., El-Ansary, A., Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J. Neuroinflam. 11 (2014), 4–12.
3. Ali, S., Mohs, A., Thomas, M., Klare, J., Ross, R., Schmitz, M.L., Martin, M.U., The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription. J. Immunol. 187 (2011), 1609–1616.
4. American Psychiatric Association, DSM 5. Diagnostic and Statistical Manual of Mental Disorders. fifth ed., 2013, American Psychiatric Publishing, Washington, DC.
5. Ashwood, P., Wakefield, A.J., Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173 (2006), 126–134.
6. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., Van de Water, J., Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 25 (2011), 40–45.
7. Aspelund, A., Antila, S., Proulx, S.T., Karlsen, T.V., Karaman, S., Detmar, M., Wiig, H., Alitalo, K., A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212 (2015), 991–999.
8. Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Mac Donald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B.G., Fitzgerald, K.A., Hornung, V., Latz, E., Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183 (2009), 787–791.
9. Bauernfeind, F., Ablasser, A., Bartok, E., Kim, S., Schmid-Burgk, J., Cavlar, T., Hornung, V., Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci. 68 (2011), 765–783.
10. Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G., Hornung, V., Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 187 (2011), 613–617.
11. Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B.R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J.N., Hecht, F.M., Picker, L.J., Lederman, M.M., Deeks, S.G., Douek, D.C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006), 1365–1371.
12. Bryant, C., Fitzgerald, K.A., Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 19 (2009), 455–464.
13. Bulau, A.M., Noldb, M.F., Lic, S., Nold-Petryb, C.A., Finka, M., Manselld, A., Schwerda, T., Hong, J., Rubartelli, A., Dinarello, C.A., Bufler, P., Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. PNAS 111 (2014), 2650–2655.
14. Chiappedi, M., Rossi, G., Rossi, M., Bejor, M., Balottin, U., Autism and classification systems: a study of 84 children. Ital. J. Pediatr., 36, 2010, 10.
15. D'Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., Giardini, O., Abnormal intestinal permeability in children with autism. Acta Paediatr. 85 (1996), 1076–1079.
16. de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., Militerni, R., Bravaccio, C., Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 51 (2010), 418–424.
17. de Theije, C.G., Wu, J., da Silva, S.L., Kamphuis, P.J., Garssen, J., Korte, S.M., Kraneveld, A.D., Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. Eur. J. Pharmacol. 668 (2011), 70–80.
18. Derikx, J.P., Evennett, N.J., Degraeuwe, P.L., Mulder, T.L., van Bijnen, A.A., van Heurn, L.W., Buurman, W.A., Heineman, E., Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 56 (2007), 1473–1475.
19. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., Tschopp, J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008), 674–677.
20. Edelson, M.B., Sonnino, R.E., Bagwell, C.E., Lieberman, J.M., Marks, W.H., Rozycki, H., Plasma intestinal fatty acid binding protein in neonates with necrotizing entercolitis: a pilot study. J. Pediatr. Surg. 34 (1999), 1452–1457.
21. Enstrom, A.M., Onore, C.E., Van de Water, J.A., Ashwood, P., Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 24 (2010), 64–71.
22. Ferrante, P., Saresella, M., Guerini, F.R., Marzorati, M., Musetti, M.C., Cazzullo, A.G., Significant association of HAL A2-DR11 with CD4 naïve decrease in autistic children. Biomed. Pharmacother. 57 (2003), 372–374.
23. Guthmann, F., Börchers, T., Wolfrum, C., Wustrack, T., Bartholomäus, S., Spener, F., Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol. Cell. Biochem. 239 (2002), 227–234.
24. Gurung, P., Anand, P.K., Malireddi, R.K., Vande Walle, L., Van Opdenbosch, N., Dillon, C.D., Weinlich, R., Green, D.R., Lamkanfi, M., Kanneganti, T.D., FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192 (2014), 1835–1846.
25. Gurung, P., Kanneganti, T.D., Novel roles for caspase-8 in IL-1β and inflammasome regulation. Am. J. Pathol. 185 (2015), 17–25.
26. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., Golenbock, D.T., The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9 (2008), 857–865.
27. Heo, Y., Zhang, Y., Gao, D., Miller, V.M., Lawrence, D.A., Aberrant immune responses in a mouse with behavioral disorders. PLoS ONE, 6, 2011, e20912, 10.1371/journal.pone.0020912.
28. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., Latz, E., Fitzgerald, K.A., AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 (2009), 514–518.
29. Horvath, G.L., Schrum, J.E., De Nardo, C.M., Latz, E., Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol. Rev. 243 (2011), 119–135.
30. Jin, C., Flavell, R.A., Molecular mechanism of NLRP3 inflammasome activation. J. Clin. Immunol. 30 (2010), 628–631.
31. Kanda, T., Fujii, H., Tani, T., Murakami, H., Suda, T., Sakai, Y., Ono, T., Hatakeyama, K., Intestinal fatty acid binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110 (1996), 339–343.
32. Kanneganti, T.D., Body-Malapel, M., Amer, A., Park, J.H., Whitfield, J., Franchi, L., Taraporewala, Z.F., Miller, D., Patton, J.T., Inohara, N., Núñez, G., Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281 (2006), 36560–36568.
33. Kitchens, R.L., Thompson, P.A., Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 11 (2005), 225–229.
34. Lamkanfi, M., Dixit, V.M., The inflammasomes. PLoS Pathog., 5, 2009, 10.1371/journal.ppat.1000510.
35. Lamkanfi, M., Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 11 (2011), 213–220.
36. Lamkanfi, M., Dixit, V.M., Mechanisms and functions of inflammasomes. Cell 157 (2014), 1013–1022.
37. Lieberman, J.M., Sacchettini, J., Marks, C., Marks, W.H., Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 121 (1997), 335–342.
38. Li, S., Hong, J., Nold, M.F., Nold-Petry, A., Azam, T., Arlanda, C., Bufler, P., Garlanda, C., Mantovani, A., Dinarello, C.A., Nold, M.F., Recombinant IL-37 inhibits LPS induced inflammation in a SIGIRRand MAPK-dependent manner. Cytokine 63 (2013), 281–288.
39. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., Dixit, V.M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006), 228–232.
40. Martinon, F., Agostini, L., Meylan, E., Tschopp, J., Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14 (2004), 1929–1934.
41. Martinon, F., Tschopp, J., Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004), 561–574.
42. Martinon, F., Mayor, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009), 229–265.
43. Masi, A., Quintana, D.S., Hickie, I.B., Guastella, A.J., Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol. Psychiatry 20 (2015), 440–446.
44. Master, S.L., Specific inflammasomes in complex diseases. Clin. Immunol. 143 (2013), 223–228.
45. Muruve, D.A., Petrilli, V., Zaiss, A.K., White, L.R., Clark, S.A., Ross, P.J., Parks, R.J., Tschopp, J., The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 (2008), 103–107.
46. Pollard, K.M., Kono, D.H., Requirements for innate immune pathways in environmentally induced autoimmunity. BMC Med., 11, 2013, 100.
47. Rezai-Zadeh, K., Gate, D., Town, T., CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?. J. Neuroimmune Pharmacol. 4 (2009), 462–475.
48. Rodriguez, J.I., Kern, J.K., Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol. 7 (2011), 205–213.
49. Rubartelli, A., Redox control of NLRP3 inflammasome activation in health and disease. J. Leukoc. Biol. 92 (2012), 951–958.
50. Saeed, A.I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., Sturn, A., Snuffin, M., Rezantsev, A., Popov, D., Ryltsov, A., Kostukovich, E., Borisovsky, I., Liu, Z., Vinsavich, A., Trush, V., Quackenbush, J., TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003), 374–378.
51. Saresella, M., Marventano, I., Guerini, F.R., Mancuso, R., Ceresa, L., Zanzottera, M., Rusconi, B., Maggioni, E., Tinelli, C., Clerici, M., An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol. Psychiatry 66 (2009), 978–984.
52. Schläger, C., Körner, H., Krueger, M., Vidoli, S., Haberl, M., Mielke, D., Brylla, E., Issekutz, T., Cabañas, C., Nelson, P.J., Ziemssen, T., Rohde, V., Bechmann, I., Lodygin, D., Odoardi, F., Flügel, A., Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature 530:7590 (2016), 349–353.
53. Schroder, K., Tschopp, J., The inflammosomes. Cell 140 (2010), 821–832.
54. Steele, A.K., Lee, E.J., Vestal, B., Hecht, D., Dong, Z., Rapaport, E., Koeppe, J., Campbell, T.B., Wilson, C.C., Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signature. PLoS ONE, 9(5), 2014, e97171.
55. Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., Yoshihara, Y., Wakuda, T., Takebayashi, K., Takagai, S., Matsumoto, K., Tsuchiya, K.J., Iwata, Y., Nakamura, K., Tsujii, M., Sugiyama, T., Mori, N., Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS ONE, 6, 2011, e20470.
56. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., Pardo, C.A., Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57 (2005), 67–81 Erratum in: Ann Neurol. 57, 304. PubMed PMID: 15546155.
57. Wen, H., Miao, E.A., Ting, J.P., Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 39 (2013), 432–441.